PetVivo Reports Fiscal 2023 Full Year Financial Results
EDINA, MN, June 29, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2023 (“fiscal 2023”).
- Conference call begins at 4:00 p.m. Central time today
EDINA, MN, June 29, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2023 (“fiscal 2023”). - Revenues were $917,162 in fiscal 2023 compared to $115,586 for fiscal 2022.
- Cost of sales was $526,817 in fiscal 2023 compared to $201,154 for fiscal 2022.
- Operating expenses increased to $9,123,797 in fiscal 2023 compared to $4,970,960 in fiscal 2022.